Congenital Cytomegalovirus: Prevalence in Buenos Aires City (cCMV Prevalence)

NCT05630898 | Unknown

• 1 other identifier: HNinosBuenosAires
• Study Type: observational
• Target: 3,000
• Locations: 1 country
• Sites: 3

Brief Summary

The goal of this observational study is to recognise the prevalnce of congenital cytomegalovirus (cCMV) and to follow up positive babies until 12 months The main questions it aims to answer are: pevalence of cCMV, cCMV clinicals outcomes during the first year of life. Participants will be screened with a salive swab for CMV DNA. Babies with positive results will be follow up for one year.

Conditions

Congenital Cytomegalovirus

Outcome Measures

Primary Outcomes (1)

• prevalence of cCMV

  newborns positive for CMV

  5 months

Secondary Outcomes (2)

• incidence of neurosensorial hearing loss during the 1° year of life

  1 year

• incidence of visual impairments detected during the 1° year of life

  1 year

Interventions

CMV PCR DIAGNOSTIC_TEST

Saliva CMV PCR

Eligibility Criteria

• Age: 1 Day - 21 Days
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

Newborns

You may qualify if:

• Newborns between 1 and 21 days
• informed consent

You may not qualify if:

• Lethal malformation

Sponsors & Collaborators

• Hospital de Niños R. Gutierrez de Buenos Aires: lead

Study Sites (3)

Clinica y maternidad Suizo Argentina

Ciudad Autonoma de Buenos Aires, Buenos Aires, C1015, Argentina

Location

Hospital Materno Infantil Ramón Sardá

Ciudad Autonoma de Buenos Aires, Buenos Aires, C1246, Argentina

Location

Hospital de Niños Ricardo Gutiérrez

Ciudad Autonoma de Buenos Aires, Buenos Aires, C1425, Argentina

Location

Related Publications (18)

• Salmerón MB. Estimación de prevalencia de infección congénita por citomegalovirus y seroprevalencia materna en Tucumán. Rev Argent Salud Pública. 2021;13:e33.

  BACKGROUND

• Marín y col. - Citomegalovirosis congénita en población asintomática de recién nacidos de un hospital público en la Región Nordeste de Argentina. Rev Argent salud Pública, 2014; 5(20): 6-10

  BACKGROUND

• Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013 Jan;26(1):86-102. doi: 10.1128/CMR.00062-12.

  PMID: 23297260 RESULT

• Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007 Jul-Aug;17(4):253-76. doi: 10.1002/rmv.535.

  PMID: 17579921 RESULT

• Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, Alford CA. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982 Apr 22;306(16):945-9. doi: 10.1056/NEJM198204223061601.

  PMID: 6278309 RESULT

• Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011 Jan 15;52(2):e11-3. doi: 10.1093/cid/ciq085.

  PMID: 21288834 RESULT

• Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutre S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017 Jun;17(6):e177-e188. doi: 10.1016/S1473-3099(17)30143-3. Epub 2017 Mar 11.

  PMID: 28291720 RESULT

• Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013 Dec;57 Suppl 4(Suppl 4):S178-81. doi: 10.1093/cid/cit629.

  PMID: 24257422 RESULT

• Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997 Apr;130(4):624-30. doi: 10.1016/s0022-3476(97)70248-8.

  PMID: 9108862 RESULT

• Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010 Jul;20(4):202-13. doi: 10.1002/rmv.655.

  PMID: 20564615 RESULT

• Gantt S, Dionne F, Kozak FK, Goshen O, Goldfarb DM, Park AH, Boppana SB, Fowler K. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection. JAMA Pediatr. 2016 Dec 1;170(12):1173-1180. doi: 10.1001/jamapediatrics.2016.2016.

  PMID: 27723885 RESULT

• Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB; National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011 Jun 2;364(22):2111-8. doi: 10.1056/NEJMoa1006561.

  PMID: 21631323 RESULT

• Pinninti SG, Ross SA, Shimamura M, Novak Z, Palmer AL, Ahmed A, Tolan RW Jr, Bernstein DI, Michaels MG, Sanchez PJ, Fowler KB, Boppana SB; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Comparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection. Pediatr Infect Dis J. 2015 May;34(5):536-7. doi: 10.1097/INF.0000000000000609.

  PMID: 25876092 RESULT

• Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Fowler KB, Boppana SB; National Institute on Deafness and Other Communication Disorders CHIMES Study. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis. 2014 Nov 1;210(9):1415-8. doi: 10.1093/infdis/jiu263. Epub 2014 May 5.

  PMID: 24799600 RESULT

• Yamamoto AY, Mussi-Pinhata MM, Marin LJ, Brito RM, Oliveira PF, Coelho TB. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol. 2006 Jul;36(3):228-30. doi: 10.1016/j.jcv.2006.03.011. Epub 2006 Jun 5.

  PMID: 16750653 RESULT

• Belec L, Brogan TV. Real-time PCR-based testing of saliva for cytomegalovirus at birth. Expert Rev Anti Infect Ther. 2011 Dec;9(12):1119-24. doi: 10.1586/eri.11.130.

  PMID: 22114962 RESULT

• Barbi M, Binda S, Primache V, Caroppo S, Dido P, Guidotti P, Corbetta C, Melotti D. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol. 2000 Sep 1;17(3):159-65. doi: 10.1016/s1386-6532(00)00089-5.

  PMID: 10996112 RESULT

• Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW Jr, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Britt WJ, Fowler KB; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010 Apr 14;303(14):1375-82. doi: 10.1001/jama.2010.423.

  PMID: 20388893 RESULT

Biospecimen

Retention: SAMPLES WITH DNA

Saliva Swab for CMV PCR

MeSH Terms

Conditions

Cytomegalovirus Infections

Condition Hierarchy (Ancestors)

Herpesviridae Infections; DNA Virus Infections; Virus Diseases; Infections

Study Officials

• Daniela Satragno, MD

  Hospital de Niños Ricardo Gutierrez

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Daniela Satragno, MD

CONTACT

+541149625649; dsatragno@gmail.com

Cecilia Enfedaque, MD

CONTACT

+541149625649; cenfedaque@yahoo.com.ar

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD

Study Record Dates

• First Submitted: November 18, 2022
• First Posted: November 30, 2022
• Study Start: April 1, 2023
• Primary Completion: September 30, 2024
• Study Completion: December 30, 2024
• Last Updated: November 30, 2022

Record last verified: 2022-11

Data Sharing

• IPD Sharing: Will not share

Locations

AR (3)